Prognostic significance of geriatric assessment in combination with laboratory parameters in elderly patients with aggressive non-Hodgkin lymphoma

Functional Decline in Older Patients With Cancer Receiving First-Line Chemotherapy

(2013) Stéphanie Hoppe et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone is beneficial but toxic in very elderly patients with diffuse large B-cell lymphoma: a population-based cohort study on treatment, toxicity and outcome

(2013) Karin Boslooper et al.   LEUKEMIA & LYMPHOMA

Predictors of Early Death Risk in Older Patients Treated With First-Line Chemotherapy for Cancer

(2012) Pierre Soubeyran et al.   JOURNAL OF CLINICAL ONCOLOGY

Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA

(2012) A. Olivieri et al.   ONCOLOGIST

Modulated Chemotherapy According to Modified Comprehensive Geriatric Assessment in 100 Consecutive Elderly Patients with Diffuse Large B-Cell Lymphoma

(2012) M. Spina et al.   ONCOLOGIST

Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium

(2011) G. Salles et al.   BLOOD

Analysis of very elderly (≥80 years) non-hodgkin lymphoma: impact of functional status and co-morbidities on outcome

(2011) Chadi Nabhan et al.   BRITISH JOURNAL OF HAEMATOLOGY

Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score

(2011) Martine Extermann et al.   CANCER

Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study

(2011) Arti Hurria et al.   JOURNAL OF CLINICAL ONCOLOGY

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial

(2011) Frédéric Peyrade et al.   LANCET ONCOLOGY

Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic in

(2010) Ranjana H. Advani et al.   BRITISH JOURNAL OF HAEMATOLOGY

Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy

(2010) A.A. Aaldriks et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Results of comprehensive geriatric assessment effect survival in patients with malignant lymphoma

(2010) Nils Winkelmann et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+B-Cell Lymphoma in the Rituximab Era

(2010) Marita Ziepert et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story

(2009) A. Bari et al.   ANNALS OF ONCOLOGY

A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy

(2009) Alessandra Tucci et al.   CANCER

Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

(2009) Massimo Federico et al.   JOURNAL OF CLINICAL ONCOLOGY

Undernutrition in elderly patients with cancer: Target for diagnosis and intervention

(2008) Christèle Blanc-Bisson et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY